These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 7164086)
1. Apoprotein b-poor very low density lipoprotein in diabetic patients without hyperlipoproteinemia. Maruhama Y; Saito F; Hikichi I; Hashimoto T; Takahashi K; Kaito I Tohoku J Exp Med; 1982 Dec; 138(4):419-25. PubMed ID: 7164086 [TBL] [Abstract][Full Text] [Related]
2. Composition of serum very-low-density and high-density lipoproteins in diabetes. Gabor J; Spain M; Kalant N Clin Chem; 1980 Aug; 26(9):1261-5. PubMed ID: 7398040 [TBL] [Abstract][Full Text] [Related]
3. The metabolic fate of plasma lipoproteins in normal subjects and in patients with insulin resistance and endogenous hypertriglyceridaemia. Kissebah AH; Alfarsi S; Adams PW; Wynn V Diabetologia; 1976 Oct; 12(5):501-9. PubMed ID: 185113 [TBL] [Abstract][Full Text] [Related]
4. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus. Kissebah AH; Alfarsi S; Evans DJ; Adams PW Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129 [TBL] [Abstract][Full Text] [Related]
5. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia. Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797 [TBL] [Abstract][Full Text] [Related]
6. Integrated study of low density lipoprotein metabolism and very low density lipoprotein metabolism in non-insulin-dependent diabetes. Howard BV; Abbott WG; Beltz WF; Harper IT; Fields RM; Grundy SM; Taskinen MR Metabolism; 1987 Sep; 36(9):870-7. PubMed ID: 3626866 [TBL] [Abstract][Full Text] [Related]
7. Catabolism of very low density lipoprotein B apoprotein in man. Reardon MF; Fidge NH; Nestel PJ J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554 [TBL] [Abstract][Full Text] [Related]
8. Serum high density lipoprotein in diabetic patients. Lopes-Virella MF; Stone PG; Colwell JA Diabetologia; 1977 Aug; 13(4):285-91. PubMed ID: 199515 [TBL] [Abstract][Full Text] [Related]
9. Alterations in very low density lipoprotein subfractions in normotriglyceridemic non-insulin-dependent diabetics. Patti L; Swinburn B; Riccardi G; Rivellese AA; Howard BV Atherosclerosis; 1991 Nov; 91(1-2):15-23. PubMed ID: 1811550 [TBL] [Abstract][Full Text] [Related]
10. [Apoproteins in dyslipoproteinemia (author's transl)]. Dewailly P Diabete Metab; 1981 Mar; 7(1):51-61. PubMed ID: 6786929 [TBL] [Abstract][Full Text] [Related]
11. Transport kinetics of plasma free fatty acid, very low density lipoprotein triglycerides and apoprotein in patients with endogenous hypertriglyceridaemia: effects of 2,2-dimethyl, 5(2, 5-xylyoxy) valeric acid therapy. Kissebah AH; Alfarsi S; Adams PW; Seed M; Folkard J; Wynn V Atherosclerosis; 1976; 24(1-2):199-218. PubMed ID: 182185 [TBL] [Abstract][Full Text] [Related]
12. Suppression by diets rich in fish oil of very low density lipoprotein production in man. Nestel PJ; Connor WE; Reardon MF; Connor S; Wong S; Boston R J Clin Invest; 1984 Jul; 74(1):82-9. PubMed ID: 6736254 [TBL] [Abstract][Full Text] [Related]
13. Hyperlipoproteinemia in spontaneously diabetic guinea pigs. Arbeeny CM; Nordin C; Edelstein D; Stram N; Gibbons N; Eder HA Metabolism; 1989 Sep; 38(9):895-900. PubMed ID: 2770534 [TBL] [Abstract][Full Text] [Related]
14. The effect of diabetic control on very low-density lipoprotein--triglyceride metabolism in patients with type II diabetes mellitus and marked hypertriglyceridemia. Dunn FL; Raskin P; Bilheimer DW; Grundy SM Metabolism; 1984 Feb; 33(2):117-23. PubMed ID: 6582347 [TBL] [Abstract][Full Text] [Related]
15. Effect of ileal exclusion on kinetics of very low density lipoprotein triglycerides in familial hypercholesterolemia. Koivisto PV; Miettinen TA Clin Chim Acta; 1986 Nov; 161(1):91-101. PubMed ID: 3815857 [TBL] [Abstract][Full Text] [Related]
16. Serum lipids and apoprotein composition (%) of the very low density lipoprotein (VLDL) fraction in two groups of diabetic patients: effects of oral as compared to insulin therapy. Pagnan A; Padovan D; Guarini P; Teodoro N; Zanetti G Acta Diabetol Lat; 1980; 17(3-4):225-8. PubMed ID: 7013397 [TBL] [Abstract][Full Text] [Related]
17. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Kissebah AH; Alfarsi S; Adams PW Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376 [TBL] [Abstract][Full Text] [Related]
18. Increased low-density-lipoprotein catabolism in myeloproliferative disorders. Ginsberg H; Gilbert HS; Gibson JC; Le NA; Brown WV Ann Intern Med; 1982 Mar; 96(3):311-6. PubMed ID: 7059093 [TBL] [Abstract][Full Text] [Related]
20. Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Kissebah AH; Alfarsi S; Adams PW; Wynn V Diabetologia; 1976 Dec; 12(6):563-71. PubMed ID: 187517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]